Growing AI Spindiag is a microfluidic diagnostics startup with a funded growth trajectory and a recent history of major rounds, presenting an opportunity to position scalable, automated POC platforms to healthcare providers seeking rapid infectious disease testing capabilities.

Strategic Spin-off As a Hahn-Schickard spin-off with a patented LabDisk platform, Spindiag offers a credible technology story for partners looking to co-develop or white-label rapid test solutions for respiratory pathogens and antimicrobial resistance screening.

Compact Automation The focus on an easy-to-use, compact, automated point-of-care system enables sales conversations with clinics, urgent-care networks, and small to mid-size laboratories seeking on-site testing with quick turnaround.

Public Funding Past government and regional funding supports credibility and potential for subsidized deployments; explore partnerships or grant-aligned programs to finance adoption of Rhonda-based diagnostics in target markets.

Global Demand Strong market demand for rapid SARS-CoV-2 and infectious disease testing, combined with a scalable platform approach, signals opportunities for cross-border sales, regional distributors, and OEM collaborations to expand deployment.